Discontinued — last reported Q4 '25
Accounts Payable
Current LiabilitiesEli Lilly Accounts Payable increased by 26.2% to $5.38B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 66.6%, from $3.23B to $5.38B. Over 5 years (FY 2020 to FY 2025), Accounts Payable shows an upward trend with a 27.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2008
Last reportedQ4 2025
How to read this metric
An increase can signal better credit terms or increased purchasing activity, while a decrease may indicate rapid payment or reduced operations.
Detailed definition
Short-term obligations owed to suppliers and vendors for goods and services purchased on credit in the ordinary course o...
Peer comparison
Efficient companies often maximize this to keep cash in the business longer, similar to other high-volume hardware and software providers.
Metric ID:
accounts_payableHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.60B | $1.57B | $1.67B | $1.43B | $1.66B | $1.68B | $1.93B | $2.02B | $2.47B | $2.44B | $2.60B | $2.47B | $2.92B | $2.89B | $3.23B | $3.44B | $4.08B | $4.26B | $5.38B |
| QoQ Change | — | -1.9% | +6.6% | -14.2% | +15.8% | +1.4% | +14.7% | +4.4% | +22.7% | -1.6% | +6.7% | -4.8% | +18.2% | -1.3% | +11.9% | +6.6% | +18.4% | +4.6% | +26.2% |
| YoY Change | — | — | — | — | +3.8% | +7.4% | +15.6% | +40.6% | +49.1% | +44.7% | +34.6% | +22.7% | +18.2% | +18.5% | +24.2% | +39.1% | +39.3% | +47.7% | +66.6% |
Range$1.43B – $5.38B
CAGR+31.0%
Avg YoY Growth+31.5%
Median YoY Growth+34.6%
Current Streak5 quarters growth
Accounts Payable at Other Companies
Frequently Asked Questions
- What is Eli Lilly's accounts payable?
- Eli Lilly (LLY) reported accounts payable of $5.38B in Q4 2025.
- How has Eli Lilly's accounts payable changed year-over-year?
- Eli Lilly's accounts payable increased by 66.6% year-over-year, from $3.23B to $5.38B.
- What is the long-term trend for Eli Lilly's accounts payable?
- Over 5 years (2020 to 2025), Eli Lilly's accounts payable has grown at a 27.3% compound annual growth rate (CAGR), from $1.61B to $5.38B.
- What does accounts payable mean?
- Money the company owes to its suppliers for recent purchases.